Stock Price Quote

GRANULES INDIA LTD.

NSE : GRANULESBSE : 532482ISIN CODE : INE101D01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE452.20-23.55 (-4.95 %)
PREV CLOSE ( ) 475.75
OPEN PRICE ( ) 475.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 51788
TODAY'S LOW / HIGH ( )450.10 478.00
52 WK LOW / HIGH ( )389.15 724.55
NSE452.55-22.5 (-4.74 %)
PREV CLOSE( ) 475.05
OPEN PRICE ( ) 474.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 452.55 (493)
VOLUME 1470837
TODAY'S LOW / HIGH( ) 450.00 479.00
52 WK LOW / HIGH ( )389.35 721
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 18-03 1991
Management Info
Krishna Prasad Chigurupati - Chairman Krishna Prasad Chigurupati - Managing Director
Registered Office

Address 15th Floor, Granules Tower,Botanical Garden Road,Kondapur,
Hyderabad,
Telangana-500084

Phone 040-69043500

Email mail@granulesindia.com

Website www.granulesindia.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE, NSE

NEWS

11Apr Granules India acquires Senn Chemicals
Granules India has completed the acquisition of Senn Chemicals AG, a Swi..
11Apr Granules India zooms on acquiring Senn
Granules India is currently trading at Rs. 451.00, up by 19.80 points or..
20Mar Granules India informs about allotment
Granules India has informed that the Share Transfer and Stakeholders Rel..
18Mar Granules India informs about disclosure
Pursuant to Regulation 30 read with Para A of part A of Schedule III and..
28Feb Granules India informs about change in
Granules India has informed that Sethu Madhavan Sankaran, shall cease to..

Financials

in Millions
QTR Dec 24 ANNUAL 24
Net Profit901.1100000000014359.18
Gross Profit 1186.01 5912.91
Operating Profit 1734.788071.37
Net Sales 8421.9637550.91

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

TTK Healthcare (BSE)
peergroup  1233.80 (0.44%)
M.Cap ( in Cr)1743.40
Jagsonpal Pharma (BSE)
peergroup  243.55 (1.82%)
M.Cap ( in Cr)1618.11
Alivus Life Sciences (BSE)
peergroup  1034.35 (0.39%)
M.Cap ( in Cr)12688.71
Oxygenta Pharma (BSE)
peergroup  85.05 (4.70%)
M.Cap ( in Cr)314.36
Bafna Pharma (BSE)
peergroup  79.74 (4.99%)
M.Cap ( in Cr)188.64

Shareholding Pattern

PROMOTERS 38.84%
NON-INSTITUTION 23.55%
MUTUAL FUNDS/UTI 11.57%
FI/BANKS/INSURANCE 10.13%
GOVERNMENT 0%
FII 0%

About Granules India Ltd.

Granules India Ltd. was incorporated in the year 1991. Its today's share price is 452.2. Its current market capitalisation stands at Rs 10962.98 Cr. In the latest quarter, company has reported Gross Sales of Rs. 37550.91 Cr and Total Income of Rs.37608.68 Cr. The company's management includes Kandiraju Venkata Sitaram Rao, Rajiv Pritidas Kakodkar, Sethurathnam Ravi, Kapil Kumar Mehan, Sucharita Rao Palepu, Arun Sawhney, Saumen Chakraborty, KB Sankar Rao, Priyanka Chigurupati, Harsha Chigurupati, Uma Devi Chigurupati, Krishna Prasad Chigurupati, Krishna Prasad Chigurupati, Chaitanya Tummala.

It is listed on the BSE with a BSE Code of 532482 , NSE with an NSE Symbol of GRANULES and ISIN of INE101D01020. It's Registered office is at 15th Floor, Granules Tower,Botanical Garden Road,KondapurHyderabad-500084, Telangana. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are BSR & Associates LLP, Kumar & Giri, SR Batliboi & Associates LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.